Qingyi Liu

559 citations
24 papers · 423 indexed · h-index 9
Topics
Esophageal Cancer Research and Treatment (2 papers)Systemic Lupus Erythematosus Research (2 papers)Gastric Cancer Management and Outcomes (2 papers)
Partner nations
ChinaUnited States

In The Last Decade

Qingyi Liu

23 papers receiving 407 citations

Peers

Qingyi Liu
Comparison fields: 5 of 75
  • Oncology 189
  • Molecular Biology 128
  • Surgery 100
  • Pulmonary and Respiratory Medicine 91
  • Cancer Research 79
Replace Brent K. Larson with:
Brent K. Larson United States
Siyuan Luan China
Ying He China
Elizabeth M. Gillies United States
Xiaotian Xia China
Akemi Kamijo Japan
Marjorie Carlson United States
Yufei Xing China
Qingyi Liu relative to Brent K. Larson United States Brent K. Larson's profile →
Citations per field
00.5×3.8×
Brent K. Larson · 1×
Citations per year

Countries citing papers authored by Qingyi Liu

Since Specialization
Citations

This map shows the geographic impact of Qingyi Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingyi Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingyi Liu more than expected).

Fields of papers citing papers by Qingyi Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingyi Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingyi Liu. The network helps show where Qingyi Liu may publish in the future.

Co-authorship network of co-authors of Qingyi Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Qingyi Liu. A scholar is included among the top collaborators of Qingyi Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingyi Liu. Qingyi Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 2
3 4
4 1
5 17
6 0
7 12
8 1
9 1
10 1
11 23
12 3
13 1
14 1
15 34
16 15
17 17
18 15
19 8
20 251

About Qingyi Liu

Qingyi Liu is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Rheumatology, having authored 24 papers that have together received 423 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (2 papers), Systemic Lupus Erythematosus Research (2 papers) and Gastric Cancer Management and Outcomes (2 papers). The work is most often cited by research in Oncology (189 citations), Cancer Research (79 citations) and Pulmonary and Respiratory Medicine (91 citations). Qingyi Liu has collaborated with scholars based in China and United States. Frequent co-authors include Yantao Tian, Xiao‐Guang Ni, J. Wang, Xiaofeng Bai, Yilei Mao, Yongfu Shao, Dong Xu, Ping Zhao, Jianxiong Wu and Jizong Zhao. Their work appears in journals such as SHILAP Revista de lepidopterología, International Journal of Hydrogen Energy and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026